News & InsightsNewsletterLegislation Hub

Foresight

Foresight
AboutContactBook DemoLog in
Start free trial
Foresight logo
All News & Insights

EU Commission Approves 4-NPnEO, 4-tert-OPnEO REACH Authorisations

REACH
24
January 2024
•
352
Dr Steven Brennan
Authorised uses include cell extraction, chromatographic purification and solvent exchange and more.
Microscope on a table in a lab
AI-Powered Assistant

AI Generated

Ask a question and get instant answers, tailored to your industry and products.

Summarise this article

AI Assistant

Want AI-powered insights like this, but tailored to your products?

Instant analysis of chemical regulations

Alerts matched to your product portfolio

Powerful workflows to streamline your work

Join 2,500+ compliance professionals already using Foresight’s insights to stay ahead of regulation.

Start free trial

Free for 28 days. No credit card needed.

We'll be in touch when the Assistant is ready.
Oops! Something went wrong while submitting the form.
Mountains

The European Commission has recently issued a series of important decisions regarding the authorisation of specific chemicals under the REACH (Registration, Evaluation, Authorisation and Restriction of Chemicals) Regulation. These decisions, outlined in documents C/2023/917 and C/2023/901, are pivotal for various industries, particularly in medical and scientific research sectors.

Under these decisions, authorisation has been granted for the use of 4-(1,1,3,3-tetramethylbutyl)phenol, ethoxylated (‘4-tert-OPnEO’) and 4-Nonylphenol, branched and linear, ethoxylated (4-NPnEO). These substances are now authorised for use in buffer solutions for a range of applications, including the production of purified proteins and quality control testing in laboratories. Such applications are essential in scientific research, development, and in vitro diagnostic procedures.

The authorisations have been granted to several companies, including Phadia GmbH, Thermo Fisher Scientific Baltics UAB, and Brahms GmbH. Additionally, RSI ChemRep Europe Ltd, representing OraSure Technologies Inc., has received authorisation for using 4-tert-OPnEO as a surfactant in in-vitro diagnostic device developer solutions for diagnosing Human Immunodeficiency Virus (HIV) and Hepatitis C Virus (HCV).

These decisions were made in accordance with Article 60(4) of the REACH Regulation, which states that the socio-economic benefits of using these substances outweigh the potential risks to human health and the environment. This highlights the European Commission's commitment to balancing the advancement of scientific and medical research with the need to protect health and the environment.

The review period for these authorisations is set until 4 January 2033, providing a significant duration for monitoring and evaluating the use of these substances. This period also allows for the potential development of safer and more environmentally friendly alternatives.

For companies in the chemical and pharmaceutical industries, understanding and adhering to these regulations is crucial. Foresight, with its deep expertise in chemical legislation, offers tailored solutions to assist businesses in navigating these complex regulatory environments. Our services ensure compliance with current regulations and prepare companies for future legislative changes, thereby reducing risks and enhancing operational effectiveness.

Stay informed about the latest in chemical legislation and discover how Foresight can support your compliance and risk management strategies by visiting our blog, Signal.

Read the source story

The European Commission has recently issued a series of important decisions regarding the authorisation of specific chemicals under the REACH (Registration, Evaluation, Authorisation and Restriction of Chemicals) Regulation. These decisions, outlined in documents C/2023/917 and C/2023/901, are pivotal for various industries, particularly in medical and scientific research sectors.

Read this article now for free!

You have read 3 articles.
Create a free account
or
Log in
to finish reading this article now.

Subscribe to our weekly digest

Sign up to receive our newsletter every Tuesday and get access to all of our content.

By creating an account, you agree to the Terms of Service and Privacy Policy.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
This is some text inside of a div block.

Trusted by professionals at

Dupont
ECHA - European Chemicals Agency
Energizer
Chemours
This is some text inside of a div block.

Get Foresight Today

Stay compliant, reduce risk, and protect your business with our AI-powered chemical policy monitoring—tailored just for you.

Global monitoring of 1,200+ sources
Expert-reviewed, trusted regulatory alerts
Instant risk identification for 350k+ substances

Ready to supercharge your policy monitoring workflow?

We’ll be in touch soon with more details and support to help you get started.
Oops! Something went wrong while submitting the form.
Share with a friend
Copy link

Related Articles

People walking on streetEU Sets 2026 Deadline for PFAS Restriction Review Affecting Over 10,000 Chemicals

August 29, 2025

Plastics packagingDenmark Confirms TMBPA as Endocrine Disruptor

August 29, 2025

Plane in skyREACH Annex XVII Update Adds New CMR Restrictions with Aviation Fuel Derogation

August 15, 2025

Foresight regulatory experts
Streamline your chemical compliance
Easy-to-use product compliance management for small and mid-sized manufacturers — mitigate risk and protect market access.
Get started
Subscribe to Foresight's newsletter
Stay ahead with the latest news & insights
Join 1,000s of compliance professionals getting the latest insights right to their inbox for free, every Tuesday.
100% free. No spam. Unsubscribe any time.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Stay ahead with the latest news & insights
Subscribe to our free weekly newsletter covering news, events, and expert insights.

Related articles

People walking on street

EU Sets 2026 Deadline for PFAS Restriction Review Affecting Over 10,000 Chemicals

EU to finalise PFAS restriction review by 2026, impacting 10,000+ chemicals. Industry must prepare for broad compliance and emissions control obligations.

29

Aug 2025

REACH
Plastics packaging

Denmark Confirms TMBPA as Endocrine Disruptor

TMBPA identified as an endocrine disruptor for human health and the environment. Denmark to propose EU harmonised classification in 2026.

29

Aug 2025

REACH
Plane in sky

REACH Annex XVII Update Adds New CMR Restrictions with Aviation Fuel Derogation

REACH Annex XVII update adds new CMR substance restrictions with a cumene exemption for aviation fuels. Industry must comply by 1 September 2025.

15

Aug 2025

REACH
Foresight
Providing critical insights, analysis, and guidance to help businesses anticipate changes, make informed decisions, and stay ahead.
News & Insights
Newsletter
Legislation Hub
Contact
About
© 2025 Foresight. All rights reserved.
SitemapTerms of servicePrivacy policyCookie policy